Congenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-saving

Abstract

Cost savings under a national program of prenatal screening for toxoplasma infection and treatment are outstanding. Our results are of relevance for health care providers by supplying economic data based on a unique national dataset including long-term follow-up of affected infants.